MktsMarkets

Kyverna Therapeutics, Inc.
NASDAQ: KYTXKey statistics
KYTX News
Stories mentioning KYTX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 30,073 | 30,014 | 30,457 | 35,816 | 37,433 | 33,483 | 29,193 | 27,321 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 41,367 | 39,282 | 38,727 | 44,410 | 47,408 | 41,041 | 38,770 | 33,435 |
| Operating Income (Loss) | (41,367) | (39,282) | (38,727) | (44,410) | (47,408) | (41,041) | (38,770) | (33,435) |
| Interest Income | 2,327 | 1,905 | 2,000 | 2,364 | 2,825 | 3,575 | 4,355 | 4,694 |
| Interest Expense | 39.00 | |||||||
| Other Expense | (21.00) | 16.00 | (53.00) | (21.00) | (27.00) | 4.00 | (45.00) | (23.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (39,728) | (37,804) | (36,787) | (42,081) | (44,635) | (37,489) | (34,492) | (28,803) |
| Earnings Per Share (Basic) | (0.66) | (0.85) | (0.85) | (0.97) | (1.03) | (0.98) | (0.80) | (0.67) |
| Earnings Per Share (Diluted) | (0.66) | (0.85) | (0.85) | (0.97) | (1.03) | (0.98) | (0.80) | (0.67) |
| Weighted Average Shares Outstanding (Basic) | 60,434 | 44,260 | 43,415 | 43,225 | 43,216 | 38,335 | 43,156 | 43,126 |
| Weighted Average Shares Outstanding (Diluted) | 60,434 | 44,260 | 43,415 | 43,225 | 43,216 | 38,335 | 43,156 | 43,126 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KYTX
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol KYTX. It last traded at $4.88 (Nov 6, 2026, 4:00 PM ET), up 5.9% on the day. That gives Kyverna Therapeutics a market capitalisation of $301.8M.
Over the past 52 weeks KYTX has traded between $4.50 and $13.67.
For the quarter ended Mar 31, 2026 it reported a net loss of $39.7M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$39.7M |
| Dec 31, 2025 | — | -$37.8M |
| Sep 30, 2025 | — | -$36.8M |
| Jun 30, 2025 | — | -$42.1M |
From Kyverna Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…